← Eichor
Condition: Opioid Induced Constipation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Opioid Induced Constipation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Phase N/A · 1 location(s) · BioDelivery Sciences International · NCT03720613Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Expe
Phase N/A · 1 location(s) · Professor Monique A. H. Steegers · NCT07231796Prevention of Opioid-induced Constipation in Patients With Advanced Cancer
Phase 4 · 13 location(s) · Amsterdam UMC, location VUmc · NCT05216328Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids
Phase 1/Phase 2 · 16 location(s) · Shionogi · NCT05588323
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.